Canada Endocrinology Drugs Research
8 comprehensive market analysis studies and research reports on the Canada Endocrinology Drugs sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 99 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Global Addison's Disease Treatment Market
CAGR: 4.1%
Study Period : 2019 - 2030
Healthcare
Categories
Healthcare
Categories
Showing 8 of 8 results in Endocrinology Drugs
Human Chorionic Gonadotropin Market
CAGR: 7.60%
Study Period : 2019 - 2030
Country Covered: Canada
Major Players:Sanzyme, Merck, Ferring Pharmaceuticals, Fresenius, Sun Pharmaceuticals Industries
Thyroid Eye Disease Treatment Market
CAGR: 9.12%
Study Period : 2019 - 2030
Country Covered: Canada
Major Players:Roche, Amgen, Novartis, Viridian Therapeutics Inc., Immunovant Inc.
Endocrinology Drugs Market
CAGR: 6.09%
Study Period : 2019 - 2030
Country Covered: Canada
Major Players:Abbvie, AstraZeneca, Novartis, Novo Nordisk, Eli Lilly and Company
Hypogonadism Treatment Market
CAGR: 6.32%
Study Period : 2019 - 2030
Country Covered: Canada
Major Players:Abbvie, Pfizer, Endo International, Eli Lilly and Company, Bayer
Acromegaly Treatment Market
CAGR: 7.40%
Study Period : 2019 - 2030
Country Covered: Canada
Major Players:Novartis, Ipsen, Pfizer, Recordati S.p.A., Amryt Pharma plc
Male Hypogonadism Market
CAGR: 5.06%
Study Period : 2019 - 2030
Country Covered: Canada
Major Players:Endo International, Abbvie, Pfizer, Teva Pharmaceutical Industries, Abbvie
Global Gout Therapeutics Market
CAGR: 7.37%
Study Period : 2019 - 2030
Country Covered: Canada
Major Players:Lannett, Horizon Therapeutics, Takeda Pharmaceuticals, GlaxoSmithKline, Regeneron Pharmaceuticals
Thyroid Gland Disorders Treatment Market
CAGR: 3.5%
Study Period : 2019 - 2030
Country Covered: Canada
Major Players:Abbvie, Merck, Pfizer, Exelixis, Viatris
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
